← Back to Patent Explorer
US4883862A Expired / Lapsed US ⏱️ 0.0 years remaining

Mercaptosuccinyl glycyl-glycyl-glycine a complex thereof with Tc-99m, and methods of making the same

Assignee: Albert Einstein College of Medicine
•
Filing: 1988-04-13
•
Granted: 1989-11-28
•
Expires: 2008-04-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The novel compound mercaptosuccinyl glycyl-glycyl-glycine (MSG 3 ) and a stable complex thereof with technetium-99m (Tc-99m) having utility as a renal agent. MSG 3 is made by coupling glycyl-glycyl-glycine with S-acetyl-mercapto succinic anhydride.

Inventors

  • 👤 Lakshman R. Chervu
  • 👤 Kuldeep K. Bhargava
  • 👤 M. Donald Blaufox

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 10:25
CPC Classifications
A; A61; A61K; A61K51/00; A61K51/02; A61K51/04; A61K51/08; A61K51/088; C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0802; C07K5/0804; C07K5/0806; A61K2123/00

Claims Analysis

Total Claims: 22
Claim 1
Independent Claim 4 words
The compound mercaptosuccinyl glycyl-glycyl-glycine.
Claim 2
Dependent Claim 4 words
The compound mercaptosuccinyl glycyl-glycyl-glycine.
Claim 3
Dependent Claim 13 words
A compound capable of forming a stable complex with technetium-99m comprising mercaptosuccinyl glycyl-glycyl-glycine.
Claim 4
Dependent Claim 13 words
A compound capable of forming a stable complex with technetium-99m comprising mercaptosuccinyl glycyl-glycyl-glycine.
Claim 5
Dependent Claim 12 words
The compound of claim 2 characterized by utility as a renal agent.
Claim 6
Dependent Claim 11 words
A compound comprising a stable complex of technetium-99m and mercaptosuccinyl glycyl-glycyl-glycine.
Claim 7
Dependent Claim 11 words
A compound comprising a stable complex of technetium-99m and mercaptosuccinyl glycyl-glycyl-glycine.
Claim 8
Dependent Claim 12 words
The compound of claim 4 characterized by utility as a renal agent.
Claim 9
Independent Claim 21 words
A method of forming a compound capable of forming a stable complex with technetium-99m comprising coupling glycyl-glycyl-glycine with S-acetyl-mercapto succinic anhydride.
Claim 10
Independent Claim 21 words
A method of forming a compound capable of forming a stable complex with technetium-99m comprising coupling glycyl-glycyl-glycine with S-acetyl-mercapto succinic anhydride.
Claim 11
Dependent Claim 12 words
The method of claim 6 wherein said compound is a renal agent.
Claim 12
Dependent Claim 9 words
The compound formed by the process of claim 6.
Claim 13
Independent Claim 36 words
A method of forming a radiolabeled compound comprising the steps of: (A) coupling glycyl-glycyl-glycine with S-acetyl-mercapto succinic anhydride to form a compound, and (B) forming a stable complex of technetium-99m and the compound of step (A).
Claim 14
Independent Claim 36 words
A method of forming a radiolabeled compound comprising the steps of: (A) coupling glycyl-glycyl-glycine with S-acetyl-mercapto succinic anhydride to form a compound, and (B) forming a stable complex of technetium-99m and the compound of step (A).
Claim 15
Dependent Claim 12 words
The method of claim 9 wherein said compound is a renal agent.
Claim 16
Dependent Claim 10 words
The radiolabeled compound formed by the process of claim 9.
Claim 17
Dependent Claim 30 words
The compound of claim 4 wherein said stable complex is formed by the reaction of mercaptosuccinyl glycyl-glycyl-glycine and a pertechnetate at room temperature in the presence of a reducing agent.
Claim 18
Dependent Claim 14 words
The compound of claim 12 wherein the stable complex is formed at room temperature.
Claim 19
Dependent Claim 17 words
The method of claim 6 wherein said coupling reaction is performed using equimolar amounts of the reactants.
Claim 20
Dependent Claim 14 words
The method of claim 14 wherein the coupling reaction is conducted at room temperature.
Claim 21
Dependent Claim 36 words
The method of claim 9 wherein the coupling reaction is conducted at room temperature using equimolar amounts of the reactants and the stable complex is formed at room temperature in the presence of a reducing agent.
Claim 22
Dependent Claim 23 words
The method of claim 16 wherein the stable complex is formed with the technitium-99m being initially present in the form of a pertechnetate.

References Cited (Backward Citations)

US2900375A Cited
US4115374A Cited
US4382081A Cited
US4709013A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-11-27 1993-05-29 1993-11-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-11-27 1997-05-29 1997-11-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-11-27 2001-05-29 2001-11-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag